• Solanesol (B8776): Protocols and QC

  2026-09-01

  Solanesol (B8776) provides a defined hydrophobic polyisoprenoid alcohol for controlled biochemical and membrane-related workflows. It is suitable for selected apoptosis research, DNA damage and repair studies, and enzyme assays when prepared in DMSO, but it should not be prepared in water or ethanol or used for diagnostic and medical purposes.

• Toremifene Citrate: From ER Biology to Translation

  2026-08-31

  A translational framework for using Toremifene Citrate to connect estrogen receptor mechanism, assay design, comparative endocrine evidence, and clinically relevant exposure considerations in breast cancer research.

• GS-441524: From Prodrug Biology to PK Insight

  2026-08-31

  GS-441524 research requires more than measuring a parent compound: it requires separating chemical stability, prodrug conversion, and intracellular activation. This evidence-led guide explains how recent LC–MS/MS findings can improve assay interpretation, formulation control, and translational pharmacokinetic decisions.

• HCAR3 Structures Reveal Agonist Selectivity

  2026-08-30

  Ye et al. used cryo-EM and cellular cAMP assays to define how selective agonists, including Acifran, recognize HCAR3 and discriminate it from HCAR2. The structures identify pocket architecture and residue-level interactions that may guide lipid signaling pathway modulation while helping researchers evaluate receptor selectivity and assay design.

• JC-1 Mitochondrial Membrane Potential Assay Kit

  2026-08-29

  This scenario-driven guide explains how the JC-1 Mitochondrial Membrane Potential Assay Kit, SKU K2002, can support apoptosis assay design, mitochondrial function analysis, and interpretation of ΔΨm changes. It combines practical controls, handling parameters, sample compatibility, and vendor-selection criteria for more defensible laboratory workflows.

• GS-441524: From Nucleoside Analog to Translational Map

  2026-08-28

  GS-441524 is more than a catalog identity: it is a mechanistic reference point for studying nucleoside activation, prodrug conversion, intracellular exposure, and antiviral assay design. New LC–MS/MS evidence on NGP-1 shows why translational teams should measure both a GS-441524 prodrug and released GS-441524 across gastric, hepatic, blood, and in vivo matrices.

• Radioiodinated Balsalazide for UC Imaging in Mice

  2026-08-28

  The reference study developed and evaluated radioiodinated balsalazide as a colon-directed tracer for detecting ulcerative colitis in mice. Its main contribution is the combination of optimized radioiodination, short-term stability testing, and comparative biodistribution, producing strong accumulation in ulcerated colon tissue and a practical framework for preclinical imaging studies.

• MG-132 (Z-LLL-al) Assay Workflows

  2026-08-27

  MG-132 (Z-LLL-al) provides a practical way to perturb proteasome-dependent protein turnover while tracking apoptosis, cell cycle arrest, oxidative stress, and autophagy-related phenotypes. This guide connects assay-ready dosing and troubleshooting with a recent mechanistic study of pathogen-driven mitophagy, while clearly distinguishing validated findings from exploratory workflow recommendations.

• Staurosporine: Mapping Kinase-Driven Motility

  2026-08-27

  Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor that can do more than trigger apoptosis. This article presents a disciplined assay strategy for using it to interrogate TBXA2R–Rho–ERM signaling, metastatic cell behavior, and kinase-network interpretation.

• Hoechst 33258 for Tumor Cell Imaging

  2026-08-26

  Hoechst 33258 provides a practical nuclear readout for live-cell imaging, fixed-cell morphology, and DNA-content measurements. In tumor-mechanics experiments, it complements confocal and optical-tweezer assays by enabling reliable cell identification, segmentation, and cell-cycle-aware interpretation without being mistaken for a direct KRas-transfer reporter.

• Y-27632: Decoding ROCK Effects in Stem Cells

  2026-08-26

  Y-27632 is a selective ROCK inhibitor for separating cytoskeletal effects from transcriptional and epigenetic changes in stem-cell assays. This article connects ROCK1/2 inhibition with the MEK–ERK–c-Myc–TERT framework while emphasizing controls, endpoint selection, and evidence boundaries.

• Ivermectin: Exposure-to-Endpoint Research Guide

  2026-08-25

  Ivermectin is a broad-spectrum anti-parasitic and versatile anti-parasitic research compound. This guide connects rigorous parasite assay design with lessons from GSDMC biology while clearly defining the evidence limits of cross-domain oncology interpretation.

• Danazol in Endocrine Assay Design

  2026-08-25

  Danazol and Danocrine offer a mechanistically rich way to perturb steroid and hypothalamic–pituitary–gonadal signaling. This article translates a 2025 rat-model study into practical assay-design decisions while defining the limits of extrapolation to endocrine and prostate cancer research.

• JC-1 Mitochondrial Membrane Potential Assay Kit Guide

  2026-08-24

  Build a ratiometric mitochondrial membrane potential assay around JC-1 fluorescence, CCCP controls, and matched treatment conditions. This practical guide connects mitochondrial function analysis to apoptosis research, including a workflow for evaluating hypoxia-activated cancer therapies.

• LGK-974 PORCN Inhibitor: Wnt Research Workflows

  2026-08-24

  LGK-974 enables upstream, nanomolar interrogation of Wnt ligand secretion in cancer cell, co-culture, and xenograft workflows. This guide pairs practical PORCN inhibition with the CDK4/6–BET findings reported in pancreatic cancer research to improve model selection, pathway validation, and troubleshooting.

8020 records 1/535 page Next 12345 下5页 Last page